For media inquires, please email press@juul.com.
October 20, 2021
Juul Labs is proud to announce its support for the National Association of Convenience Stores (NACS) and its retailer members on the implementation of…
October 1, 2021
“Over the past several years, we reset our company because while millions of adult smokers have converted to our products from cigarettes, we will…
June 28, 2021
“This settlement is consistent with our ongoing effort to reset our company and its relationship with our stakeholders, as we continue to combat underage…
May 21, 2021
Juul Labs recently published a study through Qeios analyzing the effectiveness of Enhanced Access Controls using publicly-available data from FDA’s compliance-check inspections of tobacco product retailers.
May 18, 2021
A new peer-reviewed study from Juul Labs found that found that while rates of complete switching from cigarettes to JUUL products among adult smokers who purchase JUUL products in the United Kingdom are encouraging, they are lower than switch rates among similar smokers in the United States and Canada, where higher nicotine concentration products are available.
April 27, 2021
Juul Labs’ Chief Regulatory Officer, Joe Murillo, published a piece entitled “Juul Labs: Advancing the Scientific Dialogue About Tobacco Harm Reduction” in the Food & Drug Law Institute (FDLI) newsletter.
April 26, 2021
This month we celebrate a significant milestone in our efforts to expand the body of evidence surrounding vapor products with the publication of 11 peer-reviewed studies in a monograph edition of the American Journal of Health Behavior (AJHB).
April 9, 2021
Juul Labs Canada is committed to resetting the vaping products category in Canada – this means re-earning trust by working collaboratively with regulators, policymakers…
February 24, 2021
Juul Labs today announced findings from its science and research program at the 2021 Annual Meeting of the Society for Research on Nicotine & Tobacco (SRNT), which was held virtually.
February 18, 2021
An emerging public health issue, illicit vapor products undermine underage-prevention measures and may present additional health and safety risks for adult consumers.